Aurora Value Chain Analysis
Fully Editable
Tailor To Your Needs In Excel Or Sheets
Professional Design
Trusted, Industry-Standard Templates
Pre-Built
For Quick And Efficient Use
No Expertise Is Needed
Easy To Follow
This Aurora Value Chain Analysis helps you quickly understand how Aurora creates value across its support and primary activities in one clear framework. This page already shows a real preview of the analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Support Activities
Aurora Cannabis's firm infrastructure rests on licensed sites, quality assurance, finance, legal, and regulatory controls. In fiscal 2025, Aurora Cannabis reported net revenue of C$314.6 million, showing this backbone supports scaled, compliant operations across medical and adult-use channels.
That matters in a highly regulated market because traceability and batch control have to work every day, not just on paper. Aurora Cannabis also has to keep cross-border rules aligned as it sells into Canada, Europe, and Australia.
This setup helps protect product quality, speed audits, and reduce compliance risk. In short, strong infrastructure is what lets Aurora Cannabis sell legally and keep moving products across markets.
In fiscal 2025, Aurora Cannabis reported net revenue of C$343.4 million, and that scale depends on trained cultivation, processing, lab, and commercial staff. Recruiting people who can work inside licensed facilities and follow cannabis rules helps protect product quality, safety, and compliance. In a regulated market, strong human resource management is a direct driver of consistency and lower operating risk.
In fiscal 2025, Aurora Cannabis used technology development to improve processes, refine formulations, and support cannabis-derived research. That work helps keep product quality tighter across 4 main formats: dried flower, oils, edibles, and concentrates.
Procurement
In Aurora Cannabis's 2025 fiscal year, net revenue was C$343.4 million, so procurement mattered for both margin and supply control. Procurement covers cultivation inputs, packaging, testing services, and processing materials, and tight supplier oversight helps keep quality steady and costs in line. That matters across Aurora Cannabis's domestic and international channels, where even small input swings can hit output and cash flow.
Aurora Cannabis's support activities in fiscal 2025 kept its regulated supply chain running, with net revenue of C$343.4 million backing compliance, people, tech, and procurement. Strong QA, legal, and licensed-site controls helped protect batch traceability across medical and adult-use markets. Procurement discipline also helped manage inputs, packaging, and testing costs.
| FY2025 | Key data |
|---|---|
| Net revenue | C$343.4 million |
| Markets | Canada, Europe, Australia |
| Main support areas | QA, legal, HR, procurement |
What is included in the product
Primary Activities
In fiscal 2025, Aurora Cannabis reported C$343.3 million in net revenue, and its inbound flow of plant material, inputs, packaging, and testing materials stayed tightly controlled inside licensed facilities.
That matters because every lot must be tracked on receipt, so strong inbound checks protect traceability before cultivation and processing begin.
In a regulated market, clean intake lowers compliance risk, cuts waste, and keeps product release moving faster.
Operations drive Aurora Cannabis's value creation: it cultivates, harvests, processes, extracts, and packages cannabis into dried flower, oils, edibles, and concentrates. In fiscal 2025, Aurora Cannabis reported net revenue of C$343.7 million, showing how its production line feeds every sales channel. Quality control and yield discipline matter because each gram lost cuts margin.
Its Canadian and international facilities, plus automation in processing and packaging, help keep output consistent and scale supply. Strong operations also support medical cannabis demand, where product reliability and compliance shape repeat orders.
In FY2025, Aurora used outbound logistics to move finished goods through pharmacies, medical clinics, retail stores, and export channels, linking its medical and adult-use customer segments. Aurora reported FY2025 net revenue of about C$343 million, so delivery speed and channel mix matter to cash flow. Exports also support non-Canadian demand and lower reliance on one market.
Marketing and Sales
Marketing and sales at Aurora Cannabis center on brand building, channel ties, and buyer education, especially where medical and adult-use rules differ. Aurora Cannabis sells through 3 distribution paths, so segment-specific messaging matters to reach the right patient, consumer, or partner fast. In FY2025, that mix supports revenue capture by matching product claims, compliance, and channel needs to each market.
Service
Aurora's service activity covers product information, patient and retailer support, and fast issue resolution across regulated markets. In FY2025, that post-sale work matters because cannabis buyers and channel partners depend on clear use, storage, and compliance guidance. Strong service helps build trust, repeat orders, and fewer quality or labeling escalations.
Aurora Cannabis's primary activities in FY2025 centered on tightly controlled sourcing, cultivation, processing, and distribution. Net revenue was C$343.3 million, showing the scale of its regulated production and sales flow. Strong quality checks and channel reach stayed key to margin and compliance.
| FY2025 metric | Value |
|---|---|
| Net revenue | C$343.3 million |
| Main activity | Cultivate, process, package |
| Core distribution | Medical and adult-use channels |
Preview Before You Purchase
Aurora Reference Sources
You're viewing a live preview of the actual Aurora Value Chain Analysis document.
The full version you purchase is the same file, with the complete structure, detail, and insights included.
No sample filler – just the real analysis, ready to download immediately after checkout.
Frequently Asked Questions
Aurora Cannabis's strongest support is its regulated infrastructure, because the business depends on licensed cultivation, processing, and compliance systems. Aurora Cannabis serves 2 markets, medical and adult-use, and reaches customers through 3 channel types: pharmacies, medical clinics, and retail stores. That structure supports quality control, traceability, and international distribution.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site - including articles or product references - constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.